Viewing Study NCT04080804


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-03-12 @ 1:37 PM
Study NCT ID: NCT04080804
Status: RECRUITING
Last Update Posted: 2024-12-13
First Post: 2019-09-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
Sponsor: Dan Zandberg
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module